首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1634193

全球神经外科市场 - 2025 - 2033

Global Neurosurgery Market - 2025 - 2033

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球神经外科市场规模达49.4亿美元，预计2033年将达75.4亿美元，2025-2033年预测期间复合年增长率为4.5%。

神经外科是一个专门的医学领域，涉及神经系统问题的诊断、治疗和復健。这包括大脑、脊髓、週边神经和脑血管系统。神经外科医师接受过培训，可以进行各种外科手术来治疗外伤、肿瘤、先天畸形和退化性疾病等疾病。该领域包括手术和非手术管理程序，允许采用更全面的患者护理方法，包括预防、诊断和復健。

神经外科作为一门活跃的专业，随着技术和手术的突破而不断变化。机器人辅助手术和术中影像等创新提高了手术精确度和病患治疗效果。此外，对神经系统疾病的更好理解正在推动新治疗方法的研究，这可能使神经外科医生能够治疗更复杂的神经系统疾病。最终，神经外科是现代医学的重要组成部分，因为它解决了世界各地人们所经历的一些最困难的健康问题。

市场动态：

驱动程式和限制

技术进步

技术进步预计将成为全球神经外科市场成长的重要因素。随着神经外科的发展，外科手术和设备的进步提高了各种神经系统疾病治疗的精确度和疗效。人工智慧 (AI) 和机器学习 (ML) 等现代技术的融合正在改变诊断和治疗程序，从而为患者提供更准确的评估和个人化治疗程序。

例如，2024 年3 月，中国科学院(CAS) 旗下香港研究中心推出了一款新的人工智慧(AI) 工具CARES Copilot 1.0，以协助复杂的脑部手术，即使医疗保健产业面临复杂的脑部手术。 CARES Copilot 1.0人工智慧模型帮助神经外科医生提供更有效率的临床诊断，并在充分参考的基础上做出更好的医疗判断。

微创外科手术是神经外科领域的另一项重大成就。这些方法使用的切口比典型的开放性手术更小，可以减少患者创伤、加快恢復速度并减少併发症。神经内视镜工具和机器人辅助手术系统等专用设备的引进，使得困难的手术能够更准确、更有效率地进行。因此，患者可以受益于更快的恢復时间和更好的结果，从而增加了对这些革命性手术方法的需求。

此外，神经外科市场正在经历研发的增加，重点是开发可提高手术能力的下一代设备。製造商正在逐步投资开发新的电动工具，这些工具结合了即时成像和人工智慧功能，为外科医生在手术过程中提供了无与伦比的精确度。这种对技术创新的重视不仅提高了营运效率，而且符合客製化医疗日益增长的趋势，即根据患者独特的医疗状况，根据患者的个人需求量身定制治疗方案。

例如，2024 年 4 月，Insightec 宣布在欧洲推出其下一代神经外科平台。 Exablate Prime 也获得了 CE 许可。这款革命性的设备极大地增强了现有的 Exablate Neuro 平台，该平台使用磁振造影 (MRI) 引导的聚焦超音波技术。 Exablate Prime 旨在治疗特发性震颤和帕金森氏症等药物难治性运动障碍，允许将无切口神经外科手术作为门诊手术，为患者提供一种非侵入性治疗替代方案，最大限度地缩短康復时间和住院时间。

神经外科设备成本高

神经外科设备的高成本等因素预计将阻碍全球神经外科市场。神经外科设备的高成本预计将严重阻碍全球神经外科产业的成长。随着对改进手术技术的需求不断增长，复杂设备的成本也不断增加。对于许多医疗机构来说，购买和维护先进技术的成本可能是一个重大挑战，特别是在经济有限的地区。由于持续需要投资指导员工有效地使用这些新仪器，这种情况变得更加复杂，这又增加了医院预算的成本。

例如，根据美国国立卫生研究院的数据，深部脑部刺激装置的成本从 10,000 美元到 14,000 美元不等。深部脑部刺激的手术和设备总成本（每位患者）从 27,497 美元到 35,531 美元不等。

Neurosurgery is a specialized field of medicine concerned with the diagnosis, treatment, and rehabilitation of neurological concerns. This encompasses the brain, spinal cord, peripheral nerves, and cerebrovascular system. Neurosurgeons are trained to undertake a wide range of surgical procedures to treat disorders such as traumatic injuries, tumors, congenital abnormalities, and degenerative diseases. The field comprises both operative and non-operative management procedures, allowing for a more comprehensive approach to patient care, including prevention, diagnosis, and rehabilitation.

Neurosurgery, as an active specialization, constantly changes in response to technological and surgical breakthroughs. Innovations like robotic-assisted surgery and intraoperative imaging improve procedure precision and patient outcomes. Furthermore, a better understanding of neurological diseases is driving research into new treatment methods, which may allow neurosurgeons to manage more complex neurological conditions. Ultimately, neurosurgery is an important part of modern medicine since it addresses some of the most difficult health concerns that people experience around the world.

Market Dynamics: Drivers & Restraints

Technological advancements

The Technological Advancements are expected to be a significant factor in the growth of the global neurosurgery market. As neurosurgery evolves, advances in surgical procedures and equipment improve the precision and efficacy of treatments for a variety of neurological diseases. The integration of modern technology such as artificial intelligence (AI) and machine learning (ML) is transforming diagnostic and therapeutic procedures, allowing for more accurate assessments and personalized treatment procedures for patients.

For instance, in March 2024, A Hong Kong-based research center under the Chinese Academy of Sciences (CAS) launched a new artificial intelligence (AI) tool CARES Copilot 1.0 to assist in complex brain surgery, even as the healthcare industry deals with an inadequate number of specialized databases for this procedure. CARES Copilot 1.0 AI model to help neurosurgeons provide more efficient clinical diagnoses and make better medical judgments based on sufficient references.

Minimally invasive surgical procedures are an additional significant accomplishment in neurosurgery. These approaches, which use smaller incisions than typical open surgeries, result in less patient trauma, faster recovery, and fewer complications. The introduction of specialized devices, such as neuroendoscopic tools and robotic-assisted surgical systems, has enabled difficult procedures to be performed more accurately and efficiently. As a result, patients benefit from faster recovery times and better outcomes, increasing demand for these revolutionary surgical approaches.

Furthermore, the neurosurgery market is experiencing a rise in R&D focused on developing next-generation equipment that improves surgical capabilities. Manufacturers are progressively investing in the development of new power tools that incorporate real-time imaging and AI capabilities, giving surgeons unparalleled levels of precision during procedures. This emphasis on technology innovation not only enhances operational efficiency but also corresponds with the growing trend toward customized medicine, in which therapies are tailored to the individual needs of patients based on their distinct medical profiles.

For instance, in April 2024, Insightec announced the launch of its next-generation neurosurgical platform in Europe. Exablate Prime also received CE clearance. This revolutionary device substantially enhances the existing Exablate Neuro platform, which uses magnetic resonance imaging (MRI)-guided focused ultrasound technology. Exablate Prime, designed to treat medication-refractory movement disorders such as essential tremor and Parkinson's disease, allows for incision-less neurosurgery as an outpatient operation, allowing patients a non-invasive treatment alternative that minimizes recovery time and hospital stays.

High costs of neurosurgery equipment

Factors such as high costs of neurosurgery equipment are expected to hamper the global neurosurgery market. The high costs of neurosurgical devices are expected to severely impede the growth of the global neurosurgery industry. As the need for improved surgical technology grows, so does the cost of the complex equipment. The cost of buying and maintaining advanced technology can be a significant challenge for many healthcare facilities, especially in areas with limited economies. This scenario is further complicated by the ongoing need to invest in instructing staff to utilize these new instruments efficiently, which adds another layer of cost to hospitals' budgets.

For instance, according to the National Institute of Health, the cost of a deep brain stimulation device ranges from $10,000 to $14,000. The total operative and device costs (per patient) range from $27,497 to $35,531 for deep brain stimulation.

Segment Analysis

The global neurosurgery market is segmented based on product, application, age group, end-user, and region.

Neuro interventional devices segment is expected to dominate the global neurosurgery market share

The radiofrequency coils segment is anticipated to dominate the global neurosurgery market owing to its technological advancements, recent launches and approvals, and increase in the number of neurological disorders. One of the primary benefits of neuro-interventional devices is their capacity to facilitate minimally invasive operations, which are associated with shorter recovery times, fewer postoperative problems, and less trauma for patients when compared to traditional open surgeries. These devices comprise several instruments including stents, embolic coils, and neurothrombectomy devices, all of which are intended to treat problems such as aneurysms and ischemic strokes using endovascular techniques. As healthcare practitioners become more aware of the benefits of these procedures, the demand for neuro-interventional devices is projected to increase significantly.

Furthermore, technological improvements have resulted in the creation of increasingly complex neuro-interventional devices that improve procedural accuracy and safety. Neurosurgeons may now execute difficult operations with better precision because of developments in robotics and imaging technology. This technical advancement not only improves surgical outcomes but also broadens the types of conditions that can be treated with these devices. As a result, healthcare institutions are more likely to invest in neuro-interventional technology, strengthening their position as an important segment of the neurosurgery market.

For instance, in February 2024, Royal Philips launched the new Azurion neuro biplane interventional system, which significantly improves its image-guided therapeutic system. The technology is intended to streamline neurovascular operations, allowing care teams to make faster judgments, treat more patients, and achieve better results. It has superior 2D and 3D imaging capabilities, as well as adjustable X-ray detector positioning. The device allows neuro-interventionists to carry out procedures more efficiently, perhaps increasing patient outcomes. This improves the experience for both staff and patients while also helping to reduce the cost of care. The Azurion neuro biplane system incorporates Philips' ClarityIQ low-dose imaging technology, neuro-specific tools, and services, resulting in a fully integrated solution for smooth procedural workflows, precise diagnosis, and treatment.

Moreover, in June 2024, MicroVention, a subsidiary of Terumo Corporation, launched its LVIS EVO Intraluminal Support Device in the United States. It is specifically intended for the treatment of wide-neck intracranial aneurysms. This novel device is now commercially accessible and represents a substantial improvement in neurovascular therapies.

Geographical Analysis

North America is expected to hold a significant position in the global neurosurgery market share

North America will likely account for a significant share of the global neurosurgery market, owing to its advanced healthcare infrastructure, a high prevalence of neurological disorders, technological advancements, and recent launches and approvals. One of the key drivers of the North America neurosurgery market is a strong healthcare system that allows for better surgical methods and technology. The United States, in particular, has established itself as a leader in medical technology development, with a number of major companies functioning in the neurosurgical field. These corporations constantly invest in R&D to develop new devices and improve existing ones. The existence of large manufacturers, as well as a robust regulatory environment, make it easier to introduce advanced neurosurgical devices, which enhances patient care.

For instance, in March 2024, Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced that it had launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. This launch expands upon the company's prior ENROUTE Transcarotid Stent System, offering additional configurations to better tailor the Transcarotid Artery Revascularization (TCAR) procedure to patient anatomy.

Moreover, in April 2024, Expanse ICE announced that the ICE Aspiration System had received 510(k) clearance from the U.S. Food and Drug Administration. The ICE System is specifically designed to address the complex challenges associated with peripheral thrombectomies. Blood clots are the third most common vascular disease.

Asia Pacific is growing at the fastest pace in the global neurosurgery market

The Asia Pacific region is emerging as the fastest-growing market for neurosurgery, owing to a combination of demographic trends, increased healthcare investment, recent launches, and a rising number of neurological disorders. One of the most significant technical advances in the APAC neurosurgery market is the incorporation of robotics and minimally invasive techniques. These innovations enable more accurate surgical procedures, lowering the trauma associated with traditional open surgeries. Additionally, high-definition imaging tools have transformed preoperative planning and intraoperative guidance in neurosurgery. Advanced imaging modalities, such as MRI and CT scans, provide extensive information about brain anatomy, allowing surgeons to see complicated structures before and during surgery. This ability improves surgical precision, lowers the risk of complications, and, eventually, leads to improved patient results. Furthermore, the introduction of artificial intelligence (AI) and machine learning into diagnostic and surgical technologies improves the efficiency and effectiveness of neurosurgical treatments.

For instance, in February 2024, Indian medical imaging AI company InMed AI launched a new AI-powered tool for screening traumatic brain injuries (TBI). The Neuroshield CT TBI is a decision support tool for detecting and quantifying intracranial hemorrhage, fracture, and midline shift. Utilizing AI, it automatically processes brain CT images and alerts clinicians of critical findings.

Competitive Landscape

The major global players in the global neurosurgery market include Medtronic, Abbott, Boston Scientific Corporation, Elekta, Brainlab AG, B. Braun SE, MicroVention, Inc., Aleva Neurotherapeutics, Integra LifeSciences, and Stryker among others.

Emerging Players

Neurotech Innovations, Cadence Neuroscience, and Synaptive Medical among others

Key Developments

In September 2024, ZEISS Medical Technology launched the KINEVO 900 S. The latest Robotic Visualization System is a further development of the successful ZEISS KINEVO 900 platform. With the best digital visualization, collaborative assistant functions, and connected intelligence, ZEISS KINEVO 900 S offers more clarity for complex surgical procedures in neurosurgery and other surgical disciplines.
In November 2023, Amrita Hospital, Kochi opened Kerala's first neuro endoscopy center, the Amrita Centre for Neuro Endoscopy (ACNE). The center has an expert team in skull base, cranial, spine, robotic, and pediatric endoscopy, providing specialized care in endoscopic neurosurgery.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global neurosurgery market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by Age Group
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Technological Advancements
- 4.1.3. Restraints
- 4.1.4. High Costs of Neurosurgery Equipment
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 6.1.2. Market Attractiveness Index, By Product
6.2. Neuro Interventional Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Neurosurgery Software
6.4. Neuroendoscopes
6.5. Radiosurgery Systems
6.6. Neurosurgical Ablation Devices
6.7. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Brain Tumors*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cerebrovascular Surgery
7.4. Cortical Mapping
7.5. Parkinson's Disease and Tremors
7.6. Others

8. By Age Group

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age group
- 8.1.2. Market Attractiveness Index, By Age group
8.2. Pediatric
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Adult
8.4. Geriatric

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Neurosurgery Centers
9.4. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Medtronic*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Abbott
12.3. Boston Scientific Corporation
12.4. Elekta
12.5. Brainlab AG
12.6. B. Braun SE
12.7. MicroVention, Inc.
12.8. Aleva Neurotherapeutics
12.9. Integra LifeSciences
12.10. Stryker

LIST NOT EXHAUSTIVE